222 related articles for article (PubMed ID: 15373320)
1. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
Baum S; Pavlotsky F; Shpiro D; Trau H
Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
[No Abstract] [Full Text] [Related]
2. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
[TBL] [Abstract][Full Text] [Related]
3. PUVA-cream photochemotherapy for the treatment of localized scleroderma.
Grundmann-Kollmann M; Ochsendorf F; Zollner TM; Spieth K; Sachsenberg-Studer E; Kaufmann R; Podda M
J Am Acad Dermatol; 2000 Oct; 43(4):675-8. PubMed ID: 11004625
[TBL] [Abstract][Full Text] [Related]
4. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients.
Kerscher M; Meurer M; Sander C; Volkenandt M; Lehmann P; Plewig G; Röcken M
Arch Dermatol; 1996 Nov; 132(11):1280-2. PubMed ID: 8915303
[No Abstract] [Full Text] [Related]
5. Successful treatment of scleroderma with PUVA therapy.
Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
[TBL] [Abstract][Full Text] [Related]
6. [Madecassol in the treatment of scleroderma (preliminary study)].
Szczepański A; Dabrowska H; Blaszczyk M
Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
[No Abstract] [Full Text] [Related]
7. [Piascledine in the treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
[No Abstract] [Full Text] [Related]
8. [General and local hormonal therapy in scleroderma].
Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
[No Abstract] [Full Text] [Related]
9. [Effect of piascledine treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
[No Abstract] [Full Text] [Related]
10. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
Didenko IG
Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
[No Abstract] [Full Text] [Related]
11. Salazopyrin (azulfidine) treatment in scleroderma.
Dover N
Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
[No Abstract] [Full Text] [Related]
12. Psoralen UVA therapy for linear and generalized morphea.
Morison WL
J Am Acad Dermatol; 1997 Oct; 37(4):657-9. PubMed ID: 9344214
[No Abstract] [Full Text] [Related]
13. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma].
Dovzhanskiĭ SI; Slesarenko NA
Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311
[No Abstract] [Full Text] [Related]
14. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
[No Abstract] [Full Text] [Related]
15. [Therapeutic effectiveness of treatment of patients with scleroderma at the Pyatigorsk Spa].
Braĭtsev AV; Kessel' VP; Marzeeva GI; Shliapak EA; Angelova VS
Vestn Dermatol Venerol; 1971 Oct; 45(10):35-9. PubMed ID: 5134075
[No Abstract] [Full Text] [Related]
16. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
[No Abstract] [Full Text] [Related]
17. Stimulating circulation to end stasis in scleroderma.
Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
[No Abstract] [Full Text] [Related]
18. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
19. [Dynamics of hydroxyproline content as the indicator of the severity of the course and the effectiveness of treatment of focal scleroderma].
Fedorova EG; Lashmanova AP
Vestn Dermatol Venerol; 1978 Dec; (12):18-22. PubMed ID: 570330
[No Abstract] [Full Text] [Related]
20. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
